Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin - Lele, M; Sajid, M; Wajih, N; Stouffer, G A (Circulation (New York, N.Y.), 2001)
Keywords: Abciximab; Antibodies, Monoclonal - metabolism; Antibodies, Monoclonal - pharmacology; Binding, Competitive - drug effects; Cell Adhesion - drug effects; Cell Division - drug effects; Cell Line; Cells, Cultured; Dimerization; Dose-Response Relationship, Drug; Eptifibatide; Humans; Immunoglobulin Fab Fragments - metabolism; Immunoglobulin Fab Fragments - pharmacology; Muscle, Smooth, Vascular - cytology; Muscle, Smooth, Vascular - drug effects; Muscle, Smooth, Vascular - metabolism; Peptides - metabolism; Peptides - pharmacology; Platelet Aggregation Inhibitors - metabolism; Platelet Aggregation Inhibitors - pharmacology; Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors; Prothrombin - metabolism; Receptors, Vitronectin - antagonists & inhibitors; Receptors, Vitronectin - chemistry; Receptors, Vitronectin - physiology; Thrombospondin 1 - metabolism; Thrombospondin 1 - pharmacology; Thrombospondins - metabolism; Thrombospondins - pharmacology; Tirofiban; Tyrosine - analogs & derivatives; Tyrosine - metabolism; Tyrosine - pharmacology; Vitronectin - metabolism; Vitronectin - pharmacology